Stock Market Today: Nifty Pharma Index saw steep cuts of more than 1.8% in the morning trades on Tuesday amidst Trump Tariff concerns: Aurobindo ... to boost domestic drug manufacturing as ...

Aurobindo Pharma Limited (APL), one of the worlds top ... Cumulatively, the Company has filed a total of 337 DMFs (Drug Master Files), of which 110 are with US FDA, and 133 in Europe including ...

Aurobindo Pharma were down by around 2 per cent today. According to reports, the executive order signed by Trump directs the US Food and Drug Administration (USFDA) to streamline reviews and work ...

Indian pharma ... domestic drug manufacturing. Benchmark indices, which opened slightly in the green, turned negative as pharma giants like Sun Pharma, Cipla, Lupin, and Aurobindo Pharma tumbled ...

The RSI indicator is rising, which confirms the bullish implications. Aurobindo Pharma has breached below its 50 DEMA support zones with a bearish candle. The RSI indicator is declining ...

Aurobindo Pharma share price has gained 4% in one month, but the stock has dropped nearly 10% on a year-to-date (YTD) basis. In the past one year, Aurobindo Pharma shares gained 5%, while the ...

India supplies over 45% of the generics and 15% of biosimilars used in the U.S., with major companies like Dr. Reddy’s, Aurobindo Pharma ... and drive up drug prices. America depends on ...

The pharma giant already has one GLP-1 available in pill form under the name Rybelsus. The FDA cleared that drug in 2019 for blood sugar control in adults with diabetes. Anna Windle is Novo ...

A fresh threat by US president Donald Trump on Monday that sector-specific tariffs on pharmaceuticals could be announced in the next two weeks has hammered the stocks of Indian drug-makers on ...

After the much-publicized claims of a probe in January by the National Medical Commission (NMC) against 30 doctors for accepting a foreign tour to Paris paid for by Abbvie, a pharma company ...